Clinical Trials Browser

Phase 1 × OTHER × Diabetes Mellitus, Insulin-Dependent, 12 × Clear all

NCT03293784 2026-03-30

TICIMEL

Phase 1 Completed

Diabetes Mellitus, Insulin-Dependent, 12, Melanoma

NCT06564623 2025-12-05

Targeting Driver Oncogenes With a Peptide Vaccine Plus Durvalumab and Tremelimumab for Patients With Biliary Tract Cancers (BTC)

Phase 1 Recruiting

Gastrointestinal

Diabetes Mellitus, Insulin-Dependent, 12, Biliary Tract Neoplasms, Carcinoma

NCT05235438 2023-05-24

Safety and Toxicity Study of IMM27M in Patients With Advanced Solid Tumor

Phase 1 Unknown

Diabetes Mellitus, Insulin-Dependent, 12, Neoplasms

NCT02716805 2022-10-12

Phase 1 Study of Tremelimumab, Durvalumab, High-dose Chemotherapy, + Autologous Stem Cell Transplant

Phase 1 Terminated

6 enrolled 11 charts

Diabetes Mellitus, Insulin-Dependent, 12, Multiple Myeloma

NCT00836407 2020-02-24

Ipilimumab +/- Vaccine Therapy in Treating Patients With Locally Advanced, Unresectable or Metastatic Pancreatic Cancer

Phase 1 Completed

30 enrolled 9 charts

Gastrointestinal

Diabetes Mellitus, Insulin-Dependent, 12, Pancreatic Neoplasms

NCT01216436 2015-05-25

Local Modulation of Immune Receptors to Enhance the Response to Dendritic Cell Vaccination in Metastatic Melanoma

Phase 1 Terminated

Diabetes Mellitus, Insulin-Dependent, 12, Melanoma

NCT00028431 2014-05-22

Novel Adjuvants for Peptide-Based Melanoma Vaccines

Phase 1 Completed

Diabetes Mellitus, Insulin-Dependent, 12, Melanoma, Neoplasms